Results 291 to 300 of about 182,997 (357)
DUX4 at 25: how it emerged from "junk DNA" to become the cause of facioscapulohumeral muscular dystrophy. [PDF]
Belayew A, Rosa AL, Zammit PS.
europepmc +1 more source
Disability, Subject‐Dependence, and the Bad‐Difference View
ABSTRACT Philosophers have debated on the “mere‐difference” view of disability, according to which disability as such is neutral in terms of well‐being, just like race and gender. It is contrasted with the “bad‐difference” view, which holds that disability is bad for its possessor even in a non‐ableist situation.
Shu Ishida +2 more
wiley +1 more source
A Novel LAMA2 Mutation (c.7412G>A) Was Found in a Chinese Patient With Congenital Muscular Dystrophy. [PDF]
Zhao M +5 more
europepmc +1 more source
A growing number of genetic variants linking non‐autoimmune diabetes to NDDs across different ages offer key insights about a common background of these phenotypes. These findings call for multidisciplinary approaches to care that integrate metabolic and neurological management in affected children.
Gabriele Di Pasquale +6 more
wiley +1 more source
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects. [PDF]
Chwalenia K +6 more
europepmc +1 more source
This systematic review found that while the Gross Motor Function Measure (GMFM) is widely used across 208 studies involving various pediatric conditions beyond cerebral palsy, validation studies exist for only eight conditions with generally low‐quality evidence.
Hirokazu Abe +2 more
wiley +1 more source
Visual Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD). [PDF]
Erdmann H, Abicht A, Becker K.
europepmc +1 more source
Syndrome of the Month: Bosma Arhinia Microphthalmia Syndrome
American Journal of Medical Genetics Part A, Volume 197, Issue 11, November 2025.
Katherine J. K. Patterson +2 more
wiley +1 more source
OXPHOS complex deficiency in congenital myopathy: A systematic review
This systematic review assessed oxidative phosphorylation (OXPHOS) complex dysfunction in genetically confirmed congenital myopathies (CM). Among 5841 studies screened, 23 publications, comprising 45 CM cases, met the inclusion criteria. OXPHOS dysfunction was identified in 78% of cases, particularly where enzymology was performed, with RYR1 most ...
Megan J. du Preez +4 more
wiley +1 more source
Influence of Dystrophin Isoform Deficiency on Motor Development in Duchenne Muscular Dystrophy. [PDF]
Chesshyre M +7 more
europepmc +1 more source

